ABCL — Recent News Coverage
All news mentioning ABCL in ESEN's AI-graded feed
News stories with ABCL as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on ABCL. See /coverage/ABCL for the 30-day aggregate.
INSIDERMONKEY.COM
·
2026-08-10
HIGH
BULLISH
CORR0.72
AbCellera (ABCL) Rockets 44% as Hot Flash Treatment Brightens Growth Outlook
$ABCL
◈ ESEN AI
ABCL surged 44% on news that its hot flash treatment candidate has strengthened the company's growth trajectory. This clinical or commercial milestone represents a meaningful shift in investor perception of the pipeline…
SEEKINGALPHA.COM
·
2026-08-10
LOW
NEUTRAL
CORR0.15
AbCellera Biologics Inc. (ABCL) Discusses Phase II Top Line Results for ABCL635 in Treatment of Moderate-to-Severe Hot Flashes Transcript
$ABCL
◈ ESEN AI
ABCL announced Phase II top-line results for ABCL635, a candidate targeting moderate-to-severe hot flashes. The disclosure appears to be a scheduled clinical readout presentation rather than an earnings surprise or mate…
RTTNEWS.COM
·
2026-08-10
HIGH
BULLISH
CORR0.72
AbCellera Stock Gains 37% On Positive Phase 2 Results
$ABCL
◈ ESEN AI
AbCellera Biologics (ABCL) reported positive Phase 2 efficacy and safety data for ABCL635, a therapeutic candidate targeting moderate-to-severe menopausal hot flashes. The 37% single-session rally reflects market recogn…
SEEKINGALPHA.COM
·
2026-08-06
NEUTRAL
NEUTRAL
CORR0.35
AbCellera Biologics Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ABCL) 2026-08-06
$ABCL
◈ ESEN AI
AbCellera Biologics (ABCL) released its 2026 Q2 earnings presentation, a standard quarterly disclosure event typical for publicly traded biotechnology firms. The company operates in antibody discovery and development, s…
ZACKS.COM
·
2026-07-07
LOW
NEUTRAL
CORR0.35
Are You Looking for a Top Momentum Pick? Why AbCellera Biologics Inc. (ABCL) is a Great Choice
$ABCL
◈ ESEN AI
AbCellera Biologics (ABCL) is being evaluated as a potential momentum candidate within biotech equity analysis. The article frames this as a screening exercise rather than a triggered news event, suggesting routine sect…
RTTNEWS.COM
·
2026-06-17
NEUTRAL
BULLISH
CORR0.58
Jazz Pharmaceuticals Signs Multi-Program Antibody Discovery Deal With AbCellera
$JAZZ
$ABCL
◈ ESEN AI
Jazz Pharmaceuticals and AbCellera have entered a multi-program collaboration centered on T-cell engaging multispecific antibodies, a therapeutic modality gaining traction in oncology and immunology. This partnership re…
SEEKINGALPHA.COM
·
2026-06-17
NEUTRAL
NEUTRAL
CORR0.42
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL)
$ABCL
◈ ESEN AI
ABCL presents a valuation inflection point for investors monitoring biotech innovation. The company trades at depressed levels relative to tangible balance-sheet value, suggesting the market has priced in significant ex…
EXPLORE OTHER FILTERS